NCT06005337Completed
Supporting Parents to Choose Wisely
Supporting Parents to Choose Wisely: A Multi-Method Study to Increase Knowledge and Manage Expectations for Common Acute Childhood Conditions
Source: ClinicalTrials.gov · Last updated 22 May 2025
Brief summary (registry, in English)
The goal of this multi-method study including a randomized control trial and qualitative interviews is to see how useful blogshots (an image that summarizes information) are at helping parents increase their knowledge and manage their expectations for common acute childhood conditions (e.g. sore throat, ear infection) with respect to Choosing Wisely Canada recommendations. Participants will be randomly assigned to Group A or Group B in this study. Group A will receive three of six blogshots over a 4-week period (a different blogshot will be sent by email to them each week for three weeks, then in the final week they will receive the same three blogshots in one summary email to review). Group B will receive the other three of six blogshots, following the same email sequence and timing. All participants from both groups will be asked to complete one baseline questionnaire at the start of the study and a follow-up questionnaire at week 5, month 3 and month 6 about different common acute childhood conditions, the blogshots and their content. All participants also have the option to participate in an optional semi-structured interview to give their thoughts on the blogshots and their experience in the study. Researchers will compared each participant's baseline score to their follow up scores to see if there was a change in their knowledge and expectations. By developing and evaluating evidence-based Choosing Wisely Canada resources, the researchers aim to make it easier for parents to choose wisely. Empowering parents to be part of conversations with their child's healthcare provider can improve health decision-making and reduce health system costs.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 174 (actual)
- First submitted
- 25 Jul 2023
- Start date
- 5 Jun 2023
- Primary completion date
- 23 Apr 2024
- Lead sponsor
- University of Alberta
- Diseases
- Acute lymphoblastic leukaemia, Asthma
- NCT number
- NCT06005337
What you commit to
- Study type: Interventional
- Participants enrolled: 174
- From 5 Jun 2023 to the primary completion date, 23 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Under the age of 18 years
- Does not identify as a parent or legal guardian of a child under 5 years of age
Other
- Does not live in Canada
- Unable to complete the interview and questionnaire in English (speak/read)
- No access to an electronic device (e.g. computer, tablet or smart phone), Internet and email.
Who the study is looking for
- Over the age of 18 years
- Parent or legal guardian of a child under 5 years of age
- Live in Canada
- Able to complete the questionnaire and interview in English (speak/read)
- Access to an electronic device (e.g. computer, tablet or smart phone), Internet and email.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Alberta Coordinator of this site? Confirm its status | Edmonton | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.